Publications

Detailed Information

배아줄기세포 이식과 사이토카인 투여의 복합치료술을 적용한 심근경색 치료 : Combined therapy using embryonic stem cell transplantation and cytokine administration for treatment of myocardial infarction

DC Field Value Language
dc.contributor.author조승우-
dc.contributor.author곽소정-
dc.contributor.author김일권-
dc.contributor.author최차용-
dc.contributor.author유경종-
dc.contributor.author김병수-
dc.date.accessioned2024-06-13T02:21:52Z-
dc.date.available2024-06-13T02:21:52Z-
dc.date.created2018-06-20-
dc.date.created2018-06-20-
dc.date.issued2006-03-
dc.identifier.citation조직공학과 재생의학, Vol.3 No.1, pp.52-57-
dc.identifier.issn1738-2696-
dc.identifier.urihttps://hdl.handle.net/10371/204415-
dc.description.abstractIn the present study, we tested the hypothesis that granulocyte colony-stimulating factor (G-CSF) administration would enhance the efficacy of cellular cardiomyoplasty with embryonic stem (ES) cells in infarcted myocardium. Three weeks after myocardial infarction by cryoinjury, Sprague-Dawley rats were randomized to receive either an injection of medium, ES cell transplantation, G-CSF administration, or a combination of G-CSF administration and ES cell transplantation. Prior to transplantation, ES cells were induced to differentiate into cardiomyocytes. Eight weeks after treatment, the cardiac tissue formation, neovascularization, and apoptotic activity in the infarct regions were evaluated by histology and immunohistochemistry. The left ventricular (LV) dimensions and function of the treated heart were evaluated by echocardiography. Transplanted ES cells survived and participated in the myocardial regeneration in the infarcted heart. A combination of G-CSF treatment and ES cell transplantation significantly promoted angiogenesis and reduced the infarct area and cell apoptosis in the infarcted myocardium compared with ES cell transplantation alone. The combination therapy also attenuated LV dilation, ascompared with ES cell transplantation alone. The present study demonstrates that G-CSF treatment can enhance the efficacy of cellular cardiomyoplasty by ES cell transplantation to treat myocardial infarction.-
dc.language한국어-
dc.publisher한국조직공학과 재생의학회-
dc.title배아줄기세포 이식과 사이토카인 투여의 복합치료술을 적용한 심근경색 치료-
dc.title.alternativeCombined therapy using embryonic stem cell transplantation and cytokine administration for treatment of myocardial infarction-
dc.typeArticle-
dc.citation.journaltitle조직공학과 재생의학-
dc.citation.endpage57-
dc.citation.number1-
dc.citation.startpage52-
dc.citation.volume3-
dc.identifier.kciidART001285959-
dc.description.isOpenAccessN-
dc.contributor.affiliatedAuthor최차용-
dc.contributor.affiliatedAuthor김병수-
dc.description.journalClass2-
dc.subject.keywordAuthorEmbryonic stem cell, granulocyte colony-stimulating factor, myocardial infarction, neovascularization, myocardial regeneration, cellular cardiomyoplasty-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Related Researcher

  • College of Engineering
  • School of Chemical and Biological Engineering
Research Area biomaterials, nanomedicine, regenerative medicine

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share